[2H6]-Etravirine - Names and Identifiers
[2H6]-Etravirine - Physico-chemical Properties
Molecular Formula | C20H15BrN6O
|
Molar Mass | 435.2767 |
Melting Point | 262-263°C |
Solubility | Acetone (Slightly), DMSO (Slightly), Chloroform and Methanol Mixture (Slightly) |
Appearance | Solid |
Color | White to Off-White |
Storage Condition | Refrigerator |
[2H6]-Etravirine - Introduction
Etravirine-d8(Etravirine-d8) is a drug that is a non-nucleoside reverse transcriptase inhibitor Etravirine a stable isotope labeled compound. It is used as a reference substance for stable isotope labeling in clinical and laboratory studies to determine the metabolic and pharmacokinetic properties of Etravirine.
The chemical properties of Etravirine-d8 are exactly the same as Etravirine, but its molecule contains the label of the stable isotope deuterium (D). Such labels can be detected and measured by mass spectrometry and other analytical techniques to provide quantitative information about drug metabolism pathways and elimination rates, among other things.
Etravirine-d8 is mainly used for clinical pharmacokinetic studies and drug metabolism studies. It can be used to study the absorption, distribution, metabolism and excretion of Etravirine, as well as the interaction of drugs with other compounds.
The method of preparing Etravirine-d8 is mainly to label Etravirine with deuterated reagents. The specific preparation method may vary according to different research purposes and experimental conditions.
Regarding safety information, the toxicity and side effects of the Etravirine-d8 are mainly the same as those of the original drug Etravirine. Use should follow appropriate laboratory procedures and safety guidelines to avoid direct contact or ingestion of the compound. At the same time, the use and handling of drugs also need to follow relevant laws and regulations and precautions. It is strongly recommended to consult a qualified medical professional or medicinal chemistry specialist before using the Etravirine-d8 to obtain more accurate and comprehensive information.
Last Update:2024-04-09 19:06:00